NTI on 9 news Perth Tonight, page-11

I would have liked the AMA and Australian Autism groups to endorse the Mente device, as it would add weight in applying for the rebates through the Australian reimbursements schemes. But not to be.

Anyway the 2nd shipment update and the FDA submission should be very soon so I will be watching for these triggers. Any positive update on early sales would definitely give the SP a nice boost, so watching for that possibility also.

Still recall watching SG Hiscock loading up on these after the Provisional Trial Publication. They added 2m shares in orders of 200k in the first hour of trading at 20 to 22 cents. They hold over 8%. Makes me think anything under 20 cents could be good value. Just IMO only.